CALIDI BIOTHERAPEUTICS INC

Historical 13F Holders

Symbol
CLDI
CUSIP
320703408
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 320703408 since 12/18/2024, newest first.

Filer % of Class Filed
Armistice Capital, LLC 13G
10.0% 5/15/2026
Event 3/31/2026
Gavrilov Ognian Anguelov 13D 0.3% 3/31/2026
Event 3/31/2026
Gavrilov Ognian Anguelov 13D 9.8% 3/9/2026
Event 3/9/2026
Lincoln Alternative Strategies LLC 13G/A Amendment 1 0% 2/10/2026
Event 9/18/2025
Gavrilov Ognian Anguelov 13G 7.8% 2/4/2026
Event 8/20/2025
Lincoln Alternative Strategies LLC 13G 14.5% 8/27/2025
Event 8/20/2025
Armistice Capital, LLC 13G/A Amendment 1
4.99% 8/14/2025
Event 6/30/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 1 625 $669.00
2026 Q2 23 526 k $89.3 k
2026 Q1 28 2.01 M $479 k
2025 Q4 27 448 k $525 k
2025 Q3 23 211 k $322 k